BTG Pactual Global Asset Management’s Biogen BIIB Stock Holding History

BTG Pactual Global Asset Management’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-1,160	Closed	-$490K	–	187
2015 Q1	$490K	Sell	1,160 -90	-7%	-$35.5K	0.04%	150
2014 Q4	$425K	Buy	1,250 +250	+25%	+$80.9K	0.04%	119
2014 Q3	$330K	Buy	+1,000	New	+$330K	0.04%	158
2014 Q2	–	Sell	-1,134	Closed	-$347K	–	223
2014 Q1	$347K	Buy	+1,134	New	+$360K	0.08%	133

Other funds holding BIIB

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

BTG Pactual Global Asset Management's BIIB Position: Q2 2015 in Review

BTG Pactual Global Asset Management sold out of Biogen (BIIB) in Q2 2015, closing a stake of 1,160 shares — an estimated $490K sold.

BTG Pactual Global Asset Management first reported a position in BIIB in Q1 2014 and held it in 4 quarters. The position peaked at $490K in Q1 2015. 974 funds tracked by Wall St. Rank hold BIIB as of Q2 2015.

BTG Pactual Global Asset Management reported no remaining Biogen position as of Q2 2015 after selling out during the quarter.
BTG Pactual Global Asset Management sold 1,160 Biogen shares in Q2 2015, an estimated $490K.
BTG Pactual Global Asset Management first reported a position in Biogen in Q1 2014 and held it in 4 quarters.
BTG Pactual Global Asset Management's Biogen position peaked at $490K in Q1 2015.
974 funds tracked by Wall St. Rank held Biogen as of Q2 2015.

Based on BTG Pactual Global Asset Management's 13F filing for Q2 2015, filed 12 Aug 2015.